Treatment with the fraction increased the expression of Bax, caspase-9, active caspase-3, caspase-8, LC-3, and beclin-1 and decreased the expression of Bcl-2, caspase-3, and pro-caspase-8 in cancer cells. The gene discussed is CASP3; the disease is cancer.